- Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation
- iOrganBio appoints Karol Jarzabek as Chief Operating Officer
- Ensera Design expands UK leadership team with new senior appointments
- Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine
- Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer
- Hongene Biotech receives Gates Foundation grant to drive mRNA vaccine production
- BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer
- AstronauTx appoints Adam Rosenberg as Chair of the Board
- Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer
- Angelini Pharma appoints Sergio Marullo di Condojanni as CEO
- QV Bioelectronics secures £4.5m in funding for brain cancer therapy development
- Alvotech appoints Lisa Graver as CEO
- HonorHealth Research Institute announces first patient dosed with new stroke treatment
- Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK
- Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases